Premium
Are New Asthma Therapies Needed?
Author(s) -
O'Byrne Paul M.
Publication year - 1999
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1177/009127009903900304
Subject(s) - medicine , asthma , intensive care medicine , adverse effect , patient compliance , asthma management , pharmacology , emergency medicine
For many years, effective therapy for the management of asthma has been available. Issues of adverse side effects and questionable patient compliance with current therapies have been seen as deterrents for proven beneficial agents such as the anti‐inflammatory corticosteroids and the bronchodilating β2‐agonists. As effective as available agents are, the goal of consistent efficacy and ease of use has fueled research into new therapies that are either easier to use or have a more favorable side effect profile.